Protective effects of PJ34, a novel, potent inhibitor of poly(ADP-ribose) polymerase (PARP) in in vitro and in vivo models of stroke.

No abstract is available for this paper.

• Publication year

  2001

• Venue

  International Journal of Molecular Medicine

• Publication date

  2001-03-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.3892/IJMM.7.3.255PMID 11179503
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Diabetic endothelial dysfunction: the role of poly(ADP-ribose) polymerase activation

  2001cited by this paper
• Melatonin is protective in necrotic but not in caspasedependent, free radical‐independent apoptotic neuronal cell death in primary neuronal cultures

  2000cited by this paper
• Poly(ADP-ribose) polymerase-1 in the nervous system.

  2000cited by this paper
• Role of nitric oxide in the ethylcholine aziridinium model of delayed apoptotic neurodegeneration in vivo and in vitro.

  2000cited by this paper
• Biology of nitric oxide signaling

  2000cited by this paper
• Poly(ADP‐Ribose) Synthase Inhibition Reduces Ischemic Injury and Inflammation in Neonatal Rat Brain

  2000cited by this paper
• Pathobiology of ischaemic stroke: an integrated view.

  1999cited by this paper
• Post-treatment with an inhibitor of poly(ADP-ribose) polymerase attenuates cerebral damage in focal ischemia.

  1999cited by this paper
• Stroke protection by 3-hydroxy-3-methylglutaryl (HMG)-CoA reductase inhibitors mediated by endothelial nitric oxide synthase.

  1998cited by this paper
• Role of peroxynitrite and neuronal nitric oxide synthase in the activation of poly(ADP-ribose) synthetase in a murine model of cerebral ischemia-reperfusion.

  1998cited by this paper
• Protective effects of 5-iodo-6-amino-1,2-benzopyrone, an inhibitor of poly(ADP-ribose) synthetase against peroxynitrite-induced glial damage and stroke development.

  1998cited by this paper
• Neurotoxic and neuroprotective roles of nitric oxide in cerebral ischaemia.

  1997cited by this paper
• Ischemic Brain Injury is Mediated by the Activation of Poly(ADP-Ribose)Polymerase

  1997cited by this paper
• DNA damage induced by peroxynitrite: subsequent biological effects.

  1997cited by this paper
• Poly(ADP-ribose) polymerase gene disruption renders mice resistant to cerebral ischemia

  1997cited by this paper
• Induction of tolerance in rat cortical neurons: hypoxic preconditioning

  1997cited by this paper
• DNA strand breakage, activation of poly (ADP-ribose) synthetase, and cellular energy depletion are involved in the cytotoxicity of macrophages and smooth muscle cells exposed to peroxynitrite.

  1996cited by this paper
• THE PATHOPHYSIOLOGICAL ROLE OF PEROXYNITRITE IN SHOCK, INFLAMMATION, AND ISCHEMIA‐REPERFUSION INJURY

  1996cited by this paper
• Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly.

  1996cited by this paper
• Nitric oxide neurotoxicity.

  1996cited by this paper
• Nitric oxide activation of poly(ADP-ribose) synthetase in neurotoxicity.

  1994cited by this paper
• Reversible middle cerebral artery occlusion without craniectomy in rats.

  1989cited by this paper
• Quantitative determination of glutamate mediated cortical neuronal injury in cell culture by lactate dehydrogenase efflux assay.

  1987cited by this paper

• Macrophage Niche Reconstitution Reveals Dynamic Transcriptional and Communication Networks Renal Macrophage-Epithelial Communication

  2026cites this paper
• Multicenter Stroke Preclinical Assessment Network Analysis of Cardiovascular Risk Factor Subgroups Treated With the Poly(ADP‐Ribose) Polymerase Inhibitor Veliparib

  2025cites this paper
• TRIM37–PARP1–TET1 axis maintains stemness and prevents osteoporosis by inhibiting DNMT1 alternative splicing via 5hmC regulation

  2025cites this paper
• PARP inhibition preserves cone photoreceptors in rd2 retina

  2025cites this paper
• The post-translational modification of NuMA in cancer cells is a new target for cancer eradication

  2025cites this paper
• Formononetin alleviates cerebral ischemia-reperfusion injury in rats by targeting the PARP-1/PARG/Iduna signaling pathway.

  2024cites this paper
• Emergence of cyclic hypoxia and the impact of PARP inhibitors on tumor progression

  2024cites this paper
• Mitochondrion-targeted selenium nanoparticles stabilized by Sargassum fusiforme polysaccharides increase reactive oxygen species-mediated antitumour activity.

  2024cites this paper
• Discovery of New 1,2,4-Triazole/1,3,4-Oxadiazole-Decorated Quinolinones as Agrochemical Alternatives for Controlling Viral Infection by Inhibiting the Viral Replication and Self-Assembly Process.

  2024cites this paper
• Renal macrophages and NLRP3 inflammasomes in kidney diseases and therapeutics

  2024cites this paper
• Neuroprotective strategies in acute ischemic stroke: A narrative review of recent advances and clinical outcomes

  2024cites this paper
• Natural product virtual-interact-phenotypic target characterization: A novel approach demonstrated with Salvia miltiorrhiza extract

  2024cites this paper
• PARP-1 inhibitor alleviates cerebral ischemia/reperfusion injury by reducing PARylation of HK-1 and LDH in mice.

  2024cites this paper
• A New Opportunity for “Old” Molecules: Targeting PARP1 Activity through a Non-Enzymatic Mechanism

  2023cites this paper
• Resveratrol Preconditioning Downregulates PARP1 Protein to Alleviate PARP1-Mediated Cell Death Following Cerebral Ischemia

  2023cites this paper
• The therapeutic potential of targeting regulated non-apoptotic cell death

  2023cites this paper
• Optical Modalities for Research, Diagnosis, and Treatment of Stroke and the Consequent Brain Injuries

  2022cites this paper
• Rubicon-deficiency sensitizes mice to mixed lineage kinase domain-like (MLKL)-mediated kidney ischemia-reperfusion injury

  2022cites this paper
• Molecular Mechanisms of Parthanatos and Its Role in Diverse Diseases

  2022cites this paper
• Poly (ADP-ribose) polymerase: An Overview of Mechanistic Approaches and Therapeutic Opportunities in the Management of Stroke

  2022cites this paper
• Radiation-induced neuroinflammation: a potential protective role for poly(ADP-ribose) polymerase inhibitors?

  2022cites this paper
• Gasdermin D-deficient mice are hypersensitive to acute kidney injury

  2022cites this paper
• Effects of PARP Inhibitör 3-Aminobenzamide on Impaired Mesenteric Blood Flow and Organ Injury in CLP-Induced Septic Shock Model

  2022cites this paper
• DNA damage as a mechanism of neurodegeneration in ALS and a contributor to astrocyte toxicity

  2021cites this paper
• Attenuated SIRT1 Activity Leads to PER2 Cytoplasmic Localization and Dampens the Amplitude of Bmal1 Promoter-Driven Circadian Oscillation

  2021cites this paper
• An integrative drug repositioning framework discovered a potential therapeutic agent targeting COVID-19

  2021cites this paper
• Targeting Parthanatos in Ischemic Stroke

  2021cites this paper
• Evaluation of a Low-Toxicity PARP Inhibitor as a Neuroprotective Agent for Parkinson’s Disease

  2021cites this paper
• Nucleoside Analogs Radiosensitize G0 Cells by Activating DNA End Resection and Alternative End-Joining

  2021cites this paper
• PARP-DNA trapping ability of PARP inhibitors jeopardizes astrocyte viability: implications for CNS disease therapeutics.

  2021cites this paper
• Emerging role of PARP‐1 and PARthanatos in ischemic stroke

  2021cites this paper
• Poly(ADP-ribose) polymerase inhibitor PJ34 protects against UVA-induced oxidative damage in corneal endothelium

  2021cites this paper
• Transcriptional Regulation of CCL2 by PARP1 Is a Driver for Invasiveness in Breast Cancer

  2020cites this paper
• In Vitro and Cellular Probes to Study PARP Enzyme Target Engagement.

  2020cites this paper
• Neuroprotective Effects of Activated Protein C Involve the PARP/AIF Pathway against Oxygen-Glucose Deprivation in SH-SY5Y Cells

  2020cites this paper
• The Modified Phenanthridine PJ34 Unveils an Exclusive Cell-Death Mechanism in Human Cancer Cells

  2020cites this paper
• Targeting MDM2-dependent serine metabolism as a therapeutic strategy for liposarcoma

  2020influential citation
• New PAR1 Agonist Peptide Demonstrates Protective Action in a Mouse Model of Photothrombosis-Induced Brain Ischemia

  2020cites this paper
• A data-driven drug repositioning framework discovered a potential therapeutic agent targeting COVID-19

  2020cites this paper
• Instructed Assembly as Context-Dependent Signaling for the Death and Morphogenesis of Cells.

  2019cites this paper
• The phenanthrene derivative PJ34 exclusively eradicates human pancreatic cancer cells in xenografts

  2019influential citation
• Catalytic Cascade Dehydrogenative Cross-Coupling of BH/CH and BH/NH: One-Pot Process to Carborano-Isoquinolinone.

  2019cites this paper
• Potential molecular targets of peroxynitrite in mediating blood–brain barrier damage and haemorrhagic transformation in acute ischaemic stroke with delayed tissue plasminogen activator treatment

  2018cites this paper
• PARP1 depletion improves mitochondrial and heart function in Chagas disease: Effects on POLG dependent mtDNA maintenance

  2018cites this paper
• Antimalarial Phytochemicals: Delineation of the Triterpene Asiatic Acid Malarial Anti-Disease and Pathophysiological Remedial Activities - Part I

  2018cites this paper
• 3-Aminobenzamide Blocks MAMP-Induced Callose Deposition Independently of Its Poly(ADPribosyl)ation Inhibiting Activity

  2018cites this paper
• Inhibition of Parp1 by BMN673 Effectively Sensitizes Cells to Radiotherapy by Upsetting the Balance of Repair Pathways Processing DNA Double-Strand Breaks

  2018cites this paper
• Advances in stroke pharmacology

  2018cites this paper
• Nuclear poly(ADP-ribose) activity is a therapeutic target in amyotrophic lateral sclerosis

  2018cites this paper
• Nitric Oxide and Mitochondrial Function in Neurological Diseases.

  2018cites this paper
• Exclusive destruction of mitotic spindles in human cancer cells

  2017cites this paper
• NAD+ loss, a new player in AhR biology: prevention of thymus atrophy and hepatosteatosis by NAD+ repletion

  2017cites this paper
• Structural Basis for Potency and Promiscuity in Poly(ADP-ribose) Polymerase (PARP) and Tankyrase Inhibitors.

  2017cites this paper
• Neuroprotective effects of a novel poly (ADP‐ribose) polymerase‐1 inhibitor, JPI‐289, in hypoxic rat cortical neurons

  2017cites this paper
• Protective effects of ginsenoside Rg1 against oxygen-glucose-deprivation-induced apoptosis in neural stem cells.

  2017cites this paper
• PARP inhibition protects mitochondria and reduces ROS production via PARP‐1‐ATF4‐MKP‐1‐MAPK retrograde pathway

  2017cites this paper
• Sirtuins are Unaffected by PARP Inhibitors Containing Planar Nicotinamide Bioisosteres

  2016cites this paper
• TRF2-RAP1 is required to protect telomeres from engaging in homologous recombination-mediated deletions and fusions

  2016cites this paper
• Concepts and Molecular Aspects in the Polypharmacology of PARP‐1 Inhibitors

  2016cites this paper
• Enzyme-Regulated Supramolecular Assemblies of Cholesterol Conjugates against Drug-Resistant Ovarian Cancer Cells

  2016cites this paper
• Synergistic inhibition of PARP‐1 and NF‐κB signaling downregulates immune response against recombinant AAV2 vectors during hepatic gene therapy

  2016cites this paper
• A Modular Probe Strategy for Drug Localization, Target Identification and Target Occupancy Measurement on Single Cell Level.

  2016cites this paper
• The PARP inhibitor PJ-34 sensitizes cells to UVA-induced phototoxicity by a PARP independent mechanism.

  2016cites this paper
• Frataxin Deficiency Promotes Excess Microglial DNA Damage and Inflammation that Is Rescued by PJ34

  2016cites this paper
• Collective Synthesis of Phenanthridinone through C-H Activation Involving a Pd-Catalyzed Aryne Multicomponent Reaction.

  2016cites this paper
• Poly(ADP-ribose) polymerase activation induces high mobility group box 1 release from proximal tubular cells during cisplatin nephrotoxicity.

  2016cites this paper
• PARP-1 como regulador del ciclo celular

  2015cites this paper
• The Streptococcus pyogenes NAD+ glycohydrolase modulates epithelial cell PARylation and HMGB1 release

  2015influential citation
• Intervention timing and effect of PJ34 on astrocytes during oxygen-glucose deprivation/reperfusion and cell death pathways

  2015cites this paper
• 5-Aminoisoquinolin-1-one (5-AIQ), a Water-Soluble Inhibitor of the Poly(ADP-Ribose)Polymerases (PARPs).

  2015cites this paper
• Structural Requirements of Some 2-(1-Propylpiperidin-4-yl)-1H-benzimidazole-4-carboxamide Derivatives as Poly (ADP-Ribose) Polymerase (PARP) for the Treatment of Cancer: QSAR Approach

  2015cites this paper
• Intervention timing and effect of PJ34 on astrocytes during oxygen-glucose deprivation/reperfusion and cell death pathways

  2015cites this paper
• Matrix Metalloproteinase-2 (MMP-2) Gene Deletion Enhances MMP-9 Activity, Impairs PARP-1 Degradation, and Exacerbates Hepatic Ischemia and Reperfusion Injury in Mice

  2015cites this paper
• Structural Requirements of Some 2-(1-Propylpiperidin-4-yl)-1H-benzimidazole-4-carboxamide Derivatives as Poly (ADP-Ribose) Polymerase (PARP) for the Treatment of Cancer: QSAR Approach

  2014cites this paper
• The antimitotic potential of PARP inhibitors, an unexplored therapeutic alternative.

  2014cites this paper
• Another “String to the Bow” of PJ34, a Potent Poly(ADP-Ribose)Polymerase Inhibitor: An Antiplatelet Effect through P2Y12 Antagonism?

  2014cites this paper
• Requirement for Parp-1 and DNA ligases 1 or 3 but not of Xrcc1 in chromosomal translocation formation by backup end joining

  2014cites this paper
• Parthanatos: mitochondrial‐linked mechanisms and therapeutic opportunities

  2014cites this paper
• Regulated cell death and inflammation: an auto-amplification loop causes organ failure

  2014cites this paper
• Cell-based Therapy for Acute Organ Injury: Preclinical Evidence and Ongoing Clinical Trials Using Mesenchymal Stem Cells

  2014cites this paper
• Inhibitors of the tankyrases, triple-function targets in the cancer cell

  2014cites this paper
• Hippocampus and nitric oxide.

  2014cites this paper
• Neuroprotection by the PARP inhibitor PJ34 modulates cerebral and circulating RAGE levels in rats exposed to focal brain ischemia.

  2014cites this paper
• Targeting poly(ADP-ribose)polymerase1 in neurological diseases: A promising trove for new pharmacological interventions to enter clinical translation.

  2014cites this paper
• Molecular, Cellular, and Behavioural Effects Produced by Perinatal Asphyxia: Protection by Poly (ADP-Ribose) Polymerase 1 (PARP-1) Inhibition

  2014cites this paper
• Mitochondrial Dysfunction Induces Sarm1-Dependent Cell Death in Sensory Neurons

  2014cites this paper
• Nicotinamide pre-treatment ameliorates NAD(H) hyperoxidation and improves neuronal function after severe hypoxia.

  2014cites this paper
• Influência de células tronco mesenquimais de placenta humana sobre a biologia de neurônios e astrócitos de camundongos

  2013cites this paper
• Mechanisms underlying cell death in ischemia-like damage to the rat spinal cord in vitro

  2013influential citation
• From polypharmacology to target specificity: the case of PARP inhibitors.

  2013cites this paper
• Combined therapy with PJ34, a poly(ADP‐ribose)polymerase inhibitor, reduces tissue plasminogen activator‐induced hemorrhagic transformations in cerebral ischemia in mice

  2013cites this paper
• Therapeutic applications of PARP inhibitors: anticancer therapy and beyond.

  2013cites this paper
• Supplementary Materials and Methods

  2013cites this paper
• Alteration of poly(ADP-ribose) metabolism affects murine sperm nuclear architecture by impairing pericentric heterochromatin condensation

  2013cites this paper
• Icariside II Reduces Testosterone Production by Inducing Necrosis in Rat Leydig Cells

  2013cites this paper
• Lysosomal Membrane Permeabilization as a Key Player in Brain Ischemic Cell Death: a “Lysosomocentric” Hypothesis for Ischemic Brain Damage

  2013cites this paper
• A novel approach to inhibiting human immune deficiency virus (HIV-1) infection by actively neutralizing the antibodies of reverse transcriptase system

  2013cites this paper
• Structure of human tankyrase 1 in complex with small-molecule inhibitors PJ34 and XAV939.

  2012cites this paper
• The Sound of Silence: RNAi in Poly (ADP-Ribose) Research

  2012cites this paper
• Correction of F508del-CFTR trafficking by the sponge alkaloid latonduine is modulated by interaction with PARP.

  2012cites this paper